Related Articles
Screening and antitumor effect of an anti‑CTLA‑4 nanobody
CD28 family of receptors on T cells in chronic HBV infection: Expression characteristics, clinical significance and correlations with PD-1 blockade
Enhancement of antitumor immunity by combination of anti-CTLA-4 antibody and radioimmunotherapy through the suppression of Tregs
Cytotoxic T lymphocyte-associated antigen 4 inhibition increases the antitumor activity of adoptive T-cell therapy when carried out with naïve rather than differentiated T cells
Expression levels of CD28, CTLA‑4, PD‑1 and Tim‑3 as novel indicators of T‑cell immune function in patients with chronic hepatitis B virus infection